Xcopri Coupons & Savings Card – Discount Prices from $1212.06

Xcopri is used for the treatment of partial-onset seizures in adults with epilepsy.

Xcopri (cenobamate) and Keppra (levetiracetam) are both medications used to treat seizures, but they are not the same. They belong to different classes of antiepileptic drugs and have different mechanisms of action. While both are used to manage epilepsy, their specific uses, side effects, and interactions may vary. It is important for patients to consult with their healthcare provider to determine which medication is most appropriate for their condition.

Xcopri (cenobamate) is classified as a controlled substance because it has the potential for abuse and dependence. The U.S. Drug Enforcement Administration (DEA) has placed it in Schedule V, indicating a lower potential for abuse compared to substances in Schedules I-IV, but still requiring regulation to prevent misuse.

The success rate of Xcopri (cenobamate) can vary depending on the individual and the specific condition being treated. In clinical trials, Xcopri has been shown to significantly reduce the frequency of seizures in patients with partial-onset seizures. Approximately 20-30% of patients achieved a 50% or greater reduction in seizure frequency, and some patients experienced complete seizure freedom. However, individual responses can vary, and it is important for patients to discuss their specific situation with their healthcare provider.

Cenobamate is not classified as a narcotic. It is an anticonvulsant medication used to treat partial-onset seizures in adults.